Get started
VITA 34 AGVITA 34 AGVITA 34 AG

VITA 34 AG

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals

V3V fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Vita 34 AG engages in the collection, storage, and distribution of cells, tissues, blood, and blood components for the purpose of medical applications. It also engages in the development of products and drugs based on cells, tissues, and blood for medical application. The firm produces and manufactures viral vectors and CAR-T cells. It operates through the Vita 34 and PBKM segments. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

V3V does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company